Physician profile
Richard Hoffman
NPI 1124013347
$1,847.50
in general payments reported to CMS, 2019-2025
18 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $112 · 2021: $195 · 2022: $382 · 2023: $384 · 2024: $337 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $625.65 | 2019-2025 | Freestyle Libre 3 |
| Abbvie INC. | $425.47 | 2020-2025 | |
| Novo Nordisk INC | $180.98 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Dexcom, INC. | $151.02 | 2021-2023 | Dexcom G6 Transmitter |
| Medtronic Minimed, INC. | $77.87 | 2019-2020 | |
| Pfizer INC. | $68.03 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $66.61 | 2019-2022 | |
| Harmony Biosciences LLC | $39.69 | 2023 | Wakix |
| Cequr Corporation | $28.20 | 2022-2024 | Cequr Simplicity |
| Ibsa Pharma INC. | $28.02 | 2022-2023 | Tirosint, Licart |
| Ascendis Pharma Endocrinology INC | $23.50 | 2025 | Yorvipath |
| Kyowa Kirin, INC. | $22.77 | 2023 | Crysvita |
| Lilly USA, LLC | $19.42 | 2023 | Jardiance |
| Corcept Therapeutics | $18.82 | 2024 | Korlym |
| Intuity Medical INC | $18.81 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amphastar Pharmaceuticals, INC. | $18.59 | 2024 | |
| Horizon Therapeutics Plc | $17.79 | 2022 | |
| Mannkind Corporation | $16.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.